TG Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2006 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2006 - 2019
Revenue	454.07	329	233.66	2.79	6.69	0.15	Upgrade
Revenue Growth (YoY)	30.96%	40.80%	8290.02%	-58.36%	4300.66%	-	Upgrade
Cost of Revenue	59.22	38.49	14.13	0.27	0.79	-	Upgrade
Gross Profit	394.85	290.52	219.53	2.52	5.9	0.15	Upgrade
Selling, General & Admin	186.85	154.3	122.71	95.48	128.09	107.85	Upgrade
Research & Development	122.16	94.29	76.19	125.35	222.58	165.9	Upgrade
Operating Income	85.85	41.93	20.63	-218.32	-344.77	-273.59	Upgrade
Interest Expense	-31.37	-24.03	-12.62	-10.19	-5.64	-6.33	Upgrade
Other Non-Operating Income (Expense)	11.63	7.69	5.04	4.7	2.31	0.54	Upgrade
Total Non-Operating Income (Expense)	-19.74	-16.34	-7.57	-5.5	-3.33	-5.79	Upgrade
Pretax Income	66.11	25.59	13.06	-223.81	-348.1	-279.38	Upgrade
Provision for Income Taxes	0.19	2.21	0.39	-	-	-	Upgrade
Net Income	65.92	23.38	12.67	-223.81	-348.1	-279.38	Upgrade
Net Income to Common	65.92	23.38	12.67	-223.81	-348.1	-279.38	Upgrade
Net Income Growth	-30.63%	84.52%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	146	145	142	135	132	115	Upgrade
Shares Outstanding (Diluted)	162	160	149	135	132	115	Upgrade
Shares Change (YoY)	4.63%	7.96%	9.67%	2.41%	14.64%	30.51%	Upgrade
EPS (Basic)	0.41	0.16	0.09	-1.65	-2.63	-2.42	Upgrade
EPS (Diluted)	0.37	0.15	0.09	-1.65	-2.63	-2.42	Upgrade
EPS Growth	-38.33%	66.67%	-	-	-	-	Upgrade
Free Cash Flow	-59.24	-40.56	-31.41	-176.18	-296.04	-214.86	Upgrade
Free Cash Flow Per Share	-0.37	-0.25	-0.21	-1.30	-2.24	-1.86	Upgrade
Gross Margin	86.96%	88.30%	93.95%	90.48%	88.19%	100.00%	Upgrade
Operating Margin	18.91%	12.74%	8.83%	-7838.99%	-5154.28%	-179996.05%	Upgrade
Profit Margin	14.52%	7.11%	5.42%	-8036.34%	-5204.08%	-183803.29%	Upgrade
FCF Margin	-13.05%	-12.33%	-13.44%	-6326.18%	-4425.70%	-141357.89%	Upgrade
EBITDA	86.09	42.21	21.06	-217.8	-344.28	-273.22	Upgrade
EBITDA Margin	18.96%	12.83%	9.01%	-7820.50%	-5146.90%	-179750.00%	Upgrade
EBIT	85.85	41.93	20.63	-218.32	-344.77	-273.59	Upgrade
EBIT Margin	18.91%	12.74%	8.83%	-7838.99%	-5154.28%	-179996.05%	Upgrade
Effective Tax Rate	0.28%	8.64%	2.99%	0.00%	0.00%	0.00%	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.